TipRanks
Celltrion Pharm Inc. (KR:068760)
:068760
South Korea Market
068760
Celltrion Pharm Inc.
RESEARCH TOOLSreports

Celltrion Pharm Inc. (068760) Ratios

― Followers

Celltrion Pharm Inc. Ratios

KR:068760's free cash flow for Q4 2025 was ₩0.30. For the 2025 fiscal year, KR:068760's free cash flow was decreased by ₩ and operating cash flow was ₩0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.71 1.66 1.58 1.46 1.47
Quick Ratio
 1.27 1.23 1.17 1.06 1.15
Cash Ratio
 0.18 0.18 0.18 0.08 0.15
Solvency Ratio
 0.20 0.19 0.15 0.15 0.18
Operating Cash Flow Ratio
 0.21 0.30 0.23 0.04 -0.02
Short-Term Operating Cash Flow Coverage
 0.42 0.61 0.37 0.06 -0.03
Net Current Asset Value
₩ 163.67B₩ 147.12B₩ 119.13B₩ 99.85B₩ 68.98B
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.21 0.26 0.25 0.27
Debt-to-Equity Ratio
 0.36 0.37 0.43 0.43 0.45
Debt-to-Capital Ratio
 0.26 0.27 0.30 0.30 0.31
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.01 0.06
Financial Leverage Ratio
 1.73 1.74 1.69 1.70 1.68
Debt Service Coverage Ratio
 0.48 0.46 0.31 0.30 0.34
Interest Coverage Ratio
 9.83 8.41 4.96 4.35 6.14
Debt to Market Cap
 0.08 0.04 0.05 0.04 0.07
Interest Debt Per Share
 3.74K 3.79K 4.13K 3.92K 4.55K
Net Debt to EBITDA
 1.26 1.42 2.21 2.63 2.39
Profitability Margins
Gross Profit Margin
30.06%30.53%25.53%30.79%29.21%
EBIT Margin
10.84%10.51%7.80%8.87%9.50%
EBITDA Margin
14.87%14.66%12.00%13.95%14.02%
Operating Profit Margin
10.73%10.46%7.79%9.28%9.89%
Pretax Profit Margin
9.68%9.27%6.23%6.74%7.89%
Net Profit Margin
7.42%7.22%4.60%5.47%6.72%
Continuous Operations Profit Margin
7.42%7.22%4.60%5.47%6.72%
Net Income Per EBT
76.61%77.95%73.81%81.14%85.20%
EBT Per EBIT
90.23%88.63%79.95%72.66%79.82%
Return on Assets (ROA)
5.50%5.10%3.28%3.31%4.33%
Return on Equity (ROE)
9.82%8.89%5.53%5.65%7.28%
Return on Capital Employed (ROCE)
12.63%11.79%8.82%9.19%9.84%
Return on Invested Capital (ROIC)
7.46%7.05%4.75%5.33%6.18%
Return on Tangible Assets
5.97%5.41%3.49%3.53%4.65%
Earnings Yield
2.45%1.13%0.66%0.52%1.06%
Efficiency Ratios
Receivables Turnover
 2.53 2.38 2.19 1.75 2.06
Payables Turnover
 4.54 4.74 7.62 4.54 7.18
Inventory Turnover
 3.19 3.03 3.51 2.68 3.95
Fixed Asset Turnover
 2.78 2.43 2.15 1.76 1.69
Asset Turnover
 0.74 0.71 0.71 0.61 0.64
Working Capital Turnover Ratio
 2.93 3.24 3.68 3.61 4.51
Cash Conversion Cycle
 178.42 196.85 223.01 264.69 218.93
Days of Sales Outstanding
 144.50 153.50 166.90 208.88 177.38
Days of Inventory Outstanding
 114.38 120.42 104.01 136.22 92.40
Days of Payables Outstanding
 80.46 77.07 47.90 80.41 50.85
Operating Cycle
 258.88 273.92 270.91 345.10 269.78
Cash Flow Ratios
Operating Cash Flow Per Share
 1.38K 1.95K 1.30K 201.19 -110.33
Free Cash Flow Per Share
 829.33 1.55K 1.16K 42.70 -281.74
CapEx Per Share
 547.94 404.65 137.65 158.49 171.41
Free Cash Flow to Operating Cash Flow
 0.60 0.79 0.89 0.21 2.55
Dividend Paid and CapEx Coverage Ratio
 1.85 3.23 9.46 1.27 -0.64
Capital Expenditure Coverage Ratio
 2.51 4.82 9.46 1.27 -0.64
Operating Cash Flow Coverage Ratio
 0.38 0.54 0.33 0.05 -0.03
Operating Cash Flow to Sales Ratio
 0.11 0.16 0.12 0.02 -0.01
Free Cash Flow Yield
2.13%2.01%1.51%0.05%-0.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 39.90 88.12 152.56 193.63 94.50
Price-to-Sales (P/S) Ratio
 2.97 6.37 7.01 10.59 6.36
Price-to-Book (P/B) Ratio
 3.85 7.83 8.44 10.93 6.88
Price-to-Free Cash Flow (P/FCF) Ratio
 46.47 49.85 66.22 2.22K -237.46
Price-to-Operating Cash Flow Ratio
 28.17 39.51 59.22 470.21 -606.36
Price-to-Earnings Growth (PEG) Ratio
 1.34 1.21 44.31 -6.18 -5.03
Enterprise Value Multiple
 21.24 44.85 60.63 78.57 47.73
Enterprise Value
 1.85T 3.53T 3.48T 4.26T 2.58T
EV to EBITDA
 21.47 44.85 60.63 78.57 47.73
EV to Sales
 3.19 6.57 7.28 10.96 6.69
EV to Free Cash Flow
 49.95 51.47 68.72 2.29K -249.97
EV to Operating Cash Flow
 30.08 40.80 61.46 486.52 -638.32
Tangible Book Value Per Share
 8.72K 8.87K 8.23K 7.75K 8.60K
Shareholders’ Equity Per Share
 10.08K 9.84K 9.13K 8.65K 9.73K
Tax and Other Ratios
Effective Tax Rate
 0.23 0.22 0.26 0.19 0.15
Revenue Per Share
 12.97K 12.11K 10.99K 8.93K 10.53K
Net Income Per Share
 962.41 874.91 505.39 488.57 707.91
Tax Burden
 0.77 0.78 0.74 0.81 0.85
Interest Burden
 0.89 0.88 0.80 0.76 0.83
Research & Development to Revenue
 0.03 0.04 0.03 0.03 0.02
SG&A to Revenue
 0.08 0.08 0.07 0.09 0.09
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.43 2.23 2.58 0.41 -0.16
Currency in KRW